MLV: We're Reiterating A Buy On Halozyme By: Benzinga via Benzinga April 08, 2015 at 16:36 PM EDT In a report published Wednesday, MLV & Co analysts maintained a Buy rating for Halozyme Therapeutics, Inc (NASDAQ: HALO), with a ... Read More >> Related Stocks: Halozyme Therapeutic